Sporadic inclusion body myositis: an unsolved mystery.

Sporadic inclusion body myositis (sIBM) is considered to be the most common acquired muscle disease associated with aging. It is a disabling disorder still without effective treatment. sIBM causes weakness and atrophy of the distal and proximal muscles. Involvement of quadriceps and deep finger flexors are clues to early diagnosis. Dysphagia in the course of the disease is common. Muscle biopsy shows chronic myopathic features, lymphocytic infiltration invading nonnecrotic fibbers, rimmed vacuoles and accumulation of amyloid-related proteins. It remains uncertain whether sIBM is primarily an immune-mediated inflammatory myopathy or a degenerative myopathy with an associated inflammatory component. This review describes the epidemiology and clinical features of the disease as well as the current genetic and pathogenic concepts and therapeutic approaches. Despite recent clues, in many respects sIBM remains an unsolved mystery.

[1]  Pedro Machado,et al.  Sporadic inclusion body myositis: an unsolved mystery. , 2009, Acta reumatologica portuguesa.

[2]  A. Pestronk,et al.  Inflammatory myopathies with mitochondrial pathology and protein aggregates , 2009, Journal of the Neurological Sciences.

[3]  C. Ward,et al.  Amyloid-β protein impairs Ca2+ release and contractility in skeletal muscle , 2009, Neurobiology of Aging.

[4]  Timothy Day,et al.  Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis , 2008, Journal of Clinical Neuroscience.

[5]  H. Goebel,et al.  Myopathology of non-infectious inflammatory myopathies - the current status. , 2008, Pathology, research and practice.

[6]  A. Pestronk,et al.  TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[7]  W. Engel,et al.  In inclusion-body myositis muscle fibers Parkinson-associated DJ-1 is increased and oxidized. , 2008, Free radical biology & medicine.

[8]  F. LaFerla,et al.  Inflammation induces tau pathology in inclusion body myositis model via glycogen synthase kinase‐3β , 2008, Annals of neurology.

[9]  M. Dalakas,et al.  Interrelation of inflammation and APP in sIBM: IL-1β induces accumulation of β-amyloid in skeletal muscle , 2008, Brain : a journal of neurology.

[10]  J. S. St. Sauver,et al.  Epidemiology of sporadic inclusion body myositis and polymyositis in Olmsted County, Minnesota. , 2008, The Journal of rheumatology.

[11]  Andrew G Engel,et al.  Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM , 2008, Neurology.

[12]  F. Mastaglia,et al.  Sporadic inclusion body myositis: a continuing puzzle , 2008, Neuromuscular Disorders.

[13]  P. Miossec,et al.  Cytokine response in inflammatory myopathies , 2007, Current rheumatology reports.

[14]  B. De Paepe,et al.  Chemokine Profile of Different Inflammatory Myopathies Reflects Humoral versus Cytotoxic Immune Responses , 2007, Annals of the New York Academy of Sciences.

[15]  Frank L Mastaglia,et al.  Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches , 2007, The Lancet Neurology.

[16]  G. Thickbroom,et al.  The Effectiveness of an Individualized, Home-Based Functional Exercise Program for Patients With Sporadic Inclusion Body Myositis , 2007 .

[17]  Lev Goldfarb,et al.  Inclusion body myositis with human immunodeficiency virus infection: Four cases with clonal expansion of viral‐specific T cells , 2007, Annals of neurology.

[18]  H. Hartung,et al.  The cell-specific expression of metalloproteinase-disintegrins (ADAMs) in inflammatory myopathies , 2007, Neurobiology of Disease.

[19]  F. Mastaglia,et al.  Progressive myopathy with up-regulation of MHC-I associated with statin therapy , 2007, Neuromuscular Disorders.

[20]  Steven A Greenberg,et al.  Myeloid dendritic cells in inclusion‐body myositis and polymyositis , 2007, Muscle & nerve.

[21]  Steven A Greenberg,et al.  A Local Antigen-Driven Humoral Response Is Present in the Inflammatory Myopathies1 , 2007, The Journal of Immunology.

[22]  M. Dalakas,et al.  Sporadic inclusion body myositis—diagnosis, pathogenesis and therapeutic strategies , 2006, Nature Clinical Practice Neurology.

[23]  I. Lundberg,et al.  Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis , 2006, Annals of the rheumatic diseases.

[24]  Frank M LaFerla,et al.  Genetically augmenting Abeta42 levels in skeletal muscle exacerbates inclusion body myositis-like pathology and motor deficits in transgenic mice. , 2006, The American journal of pathology.

[25]  W. Engel,et al.  Parkin and its association with alpha-synuclein and AbetaPP in inclusion-body myositis and AbetaPP-overexpressing cultured human muscle fibers. , 2006, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

[26]  N. Romero,et al.  CAPN3 mutations in patients with idiopathic eosinophilic myositis , 2006 .

[27]  F. Mastaglia,et al.  Sporadic inclusion body myositis in Japanese is associated with the MHC ancestral haplotype 52.1 , 2006, Neuromuscular Disorders.

[28]  Marinos C. Dalakas,et al.  Therapeutic targets in patients with inflammatory myopathies: Present approaches and a look to the future , 2006, Neuromuscular Disorders.

[29]  Vincent J. Caiozzo,et al.  Pathogenic accumulation of APP in fast twitch muscle of IBM patients and a transgenic model , 2006, Neurobiology of Aging.

[30]  W. Engel,et al.  Inclusion-body myositis , 2006, Neurology.

[31]  R. Griggs.  The current status of treatment for inclusion-body myositis , 2006, Neurology.

[32]  J. Mendell,et al.  Pilot trial of etanercept in the treatment of inclusion-body myositis , 2006, Neurology.

[33]  G. Kollberg,et al.  Mitochondrial abnormalities in inclusion-body myositis , 2006, Neurology.

[34]  G. Pinkus,et al.  Plasma cells in muscle in inclusion body myositis and polymyositis , 2005, Neurology.

[35]  M. Carrington,et al.  Immunogenetic Risk and Protective Factors for the Idiopathic Inflammatory Myopathies: Distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 Allelic Profiles and Motifs Define Clinicopathologic Groups in Caucasians , 2005, Medicine.

[36]  Christopher Lindberg,et al.  Diagnosis, pathogenesis and treatment of inclusion body myositis , 2005, Current opinion in neurology.

[37]  P. Park,et al.  Discovering statistically significant pathways in expression profiling studies. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Dalakas,et al.  Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes. , 2005, Brain : a journal of neurology.

[39]  W. Engel,et al.  Molecular pathology and pathogenesis of inclusion‐body myositis , 2005, Microscopy research and technique.

[40]  Reinhard Hohlfeld,et al.  Immunobiology of muscle: advances in understanding an immunological microenvironment. , 2005, Trends in immunology.

[41]  E. Hoffman,et al.  Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. , 2005, Arthritis and rheumatism.

[42]  J. Piette,et al.  Familial inflammatory inclusion body myositis , 2005, Annals of the rheumatic diseases.

[43]  I. Lundberg,et al.  The role of exercise in the rehabilitation of idiopathic inflammatory myopathies , 2005, Current opinion in rheumatology.

[44]  S. Eustace,et al.  A comparison of inflammatory myopathies at whole-body turbo STIR MRI. , 2005, Clinical radiology.

[45]  B. Chetaille,et al.  Expression of the β chemokines CCL3, CCL4, CCL5 and their receptors in idiopathic inflammatory myopathies , 2005, Neuropathology and applied neurobiology.

[46]  J. Verschuuren,et al.  Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis , 2004, Neurology.

[47]  M. Zwarts,et al.  Primary respiratory failure in inclusion body myositis , 2004, Neurology.

[48]  M. V. von Herrath,et al.  Initiation of autoimmunity. , 2004, Current opinion in immunology.

[49]  Janice L Holton,et al.  Is it really myositis? A consideration of the differential diagnosis , 2004, Current opinion in rheumatology.

[50]  F. Mastaglia,et al.  Two major histocompatibility complex haplotypes influence susceptibility to sporadic inclusion body myositis: critical evaluation of an association with HLA-DR3. , 2004, Tissue antigens.

[51]  M. Dalakas,et al.  Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis , 2004, Current opinion in neurology.

[52]  A. Gessain,et al.  Direct Evidence for a Chronic CD8+-T-Cell-Mediated Immune Reaction to Tax within the Muscle of a Human T-Cell Leukemia/Lymphoma Virus Type 1-Infected Patient with Sporadic Inclusion Body Myositis , 2004, Journal of Virology.

[53]  Randomized pilot trial of high-dose βINF-1a in patients with inclusion body myositis , 2004, Neurology.

[54]  M. Tarnopolsky,et al.  Injection of botulinum toxin A to the upper esophageal sphincter for oropharyngeal dysphagia in two patients with inclusion body myositis. , 2004, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[55]  H. Reichmann,et al.  Apolipoprotein E and Alpha-1-Antichymotrypsin Polymorphisms in Sporadic Inclusion Body Myositis , 2004, European Neurology.

[56]  M. Dalakas,et al.  Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity. , 2004, Brain : a journal of neurology.

[57]  Isidro Ferrer,et al.  Proteasomal Expression, Induction of Immunoproteasome Subunits, and Local MHC Class I Presentation in Myofibrillar Myopathy and Inclusion Body Myositis , 2004, Journal of neuropathology and experimental neurology.

[58]  A. Pestronk,et al.  Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein , 2004, Nature Genetics.

[59]  Geoffrey Burnstock,et al.  Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice , 2004, Nature Medicine.

[60]  K. Ohno,et al.  Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients. , 2004, Brain : a journal of neurology.

[61]  G. Burnstock,et al.  The effect of treatment with BRX-220, a co-inducer of heat shock proteins, on sensory fibers of the rat following peripheral nerve injury , 2003, Experimental Neurology.

[62]  W. Engel,et al.  Proposed pathogenetic cascade of inclusion-body myositis: importance of amyloid-&bgr;, misfolded proteins, predisposing genes, and aging , 2003, Current opinion in rheumatology.

[63]  Rolf Schröder,et al.  Analysis of HLA class I and II alleles in sporadic inclusion-body myositis , 2003, Journal of Neurology.

[64]  Yasuto Itoyama,et al.  Familial inclusion body myositis: a report on two Japanese sisters. , 2003, Internal medicine.

[65]  R. Hohlfeld,et al.  Polymyositis and dermatomyositis , 2003, The Lancet.

[66]  L. Morandi,et al.  Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study , 2003, Journal of Neuroimmunology.

[67]  A. Oldfors,et al.  Inclusion Body Myositis: Clonal Expansions of Muscle‐Infiltrating T Cells Persist Over Time , 2003, Scandinavian journal of immunology.

[68]  A. Oldfors,et al.  Anti–T-lymphocyte globulin treatment in inclusion body myositis , 2003, Neurology.

[69]  S. Mitrani‐Rosenbaum,et al.  Distal myopathy with rimmed vacuoles is allelic to hereditary inclusion body myopathy , 2003, Neurology.

[70]  B. Mincey,et al.  Inclusion body myositis associated with celiac sprue and idiopathic thrombocytopenic purpura. , 2003, Southern medical journal.

[71]  S. Mitrani‐Rosenbaum,et al.  Hereditary inclusion body myopathy , 2003, Neurology.

[72]  G. Karkavelas,et al.  Inclusion body myositis in a patient with a presumed diagnosis of post-polio syndrome , 2003, Journal of Neurology.

[73]  Jeong W. Pak,et al.  Mitochondrial DNA mutations as a fundamental mechanism in physiological declines associated with aging , 2003, Aging cell.

[74]  F. Mastaglia,et al.  Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. , 2002, Rheumatic diseases clinics of North America.

[75]  A. Oldfors,et al.  Inclusion body myositis: morphological clues to correct diagnosis , 2002, Neuromuscular Disorders.

[76]  S. Eustace,et al.  Whole-body MR imaging in the diagnosis of polymyositis. , 2002, AJR. American journal of roentgenology.

[77]  W. Engel,et al.  Inclusion-body myositis and myopathies: different etiologies, possibly similar pathogenic mechanisms , 2002, Current opinion in neurology.

[78]  P. Grenier,et al.  Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis. , 2002, The Journal of rheumatology.

[79]  J. Malley,et al.  Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis. , 2002, Arthritis and rheumatism.

[80]  G. Burnstock,et al.  Upregulation of Heat Shock Proteins Rescues Motoneurones from Axotomy-Induced Cell Death in Neonatal Rats , 2002, Experimental Neurology.

[81]  J. Schröder,et al.  Differential expression of chemokines in inflammatory myopathies , 2002, Neurology.

[82]  K J Felice,et al.  A pilot randomized trial of oxandrolone in inclusion body myositis , 2002, Neurology.

[83]  B. Schoser,et al.  Matrix metalloproteinases in inflammatory myopathies: enhanced immunoreactivity near atrophic myofibers , 2002, Acta neurologica Scandinavica.

[84]  A. Tzioufas,et al.  Primary Sjögren's syndrome associated with inclusion body myositis. , 2002, Rheumatology.

[85]  A. Zwinderman,et al.  Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo , 2002, Annals of neurology.

[86]  W. Engel,et al.  Three lipoprotein receptors and cholesterol in inclusion-body myositis muscle , 2002, Neurology.

[87]  P. Laforêt,et al.  Intravenous immunoglobulin for dysphagia of inclusion body myositis , 2002, Neurology.

[88]  Mark A. Levenstien,et al.  Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. , 2001, Molecular genetics and metabolism.

[89]  Lippincott Williams Wilkins,et al.  Randomized pilot trial of βINF1a (Avonex) in patients with inclusion body myositis , 2002, Neurology.

[90]  F L Mastaglia,et al.  Patterns of muscle involvement in inclusion body myositis: Clinical and magnetic resonance imaging study , 2001, Muscle & nerve.

[91]  A. Yu,et al.  Bcl-2, Bcl-x, and Bax expression by immunohistochemistry in inclusion body myositis: a study of 27 cases. , 2001, Archives of pathology & laboratory medicine.

[92]  Tsviya Olender,et al.  The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy , 2001, Nature Genetics.

[93]  K J Felice,et al.  Inclusion Body Myositis in Connecticut: Observations in 35 Patients During an 8-Year Period , 2001, Medicine.

[94]  R. Griggs,et al.  A prospective natural history study of inclusion body myositis , 2001, Neurology.

[95]  N. Olsen,et al.  Utility of magnetic resonance imaging in the evaluation of patients with inflammatory myopathies , 2001, Current rheumatology reports.

[96]  H. Reichmann,et al.  Prion codon 129 homozygosity and sporadic inclusion body myositis , 2001, Neurology.

[97]  K. Moons,et al.  Rimmed vacuoles and the added value of SMI-31 staining in diagnosing sporadic inclusion body myositis , 2001, Neuromuscular Disorders.

[98]  J. Viallard,et al.  Macrophagic myofasciitis associated with inclusion body myositis: a report of three cases , 2001, Neuromuscular Disorders.

[99]  A. Wilkinson,et al.  AAA+ superfamily ATPases: common structure–diverse function , 2001, Genes to cells : devoted to molecular & cellular mechanisms.

[100]  Kenneth M. Rosen,et al.  β-Amyloid Peptide Expression Is Sufficient for Myotube Death: Implications for Human Inclusion Body Myopathy , 2001, Molecular and Cellular Neuroscience.

[101]  W. Bradley,et al.  Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory polyneuropathy and inclusion body myositis , 2001, Journal of the Neurological Sciences.

[102]  S. Spector,et al.  A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM , 2001, Neurology.

[103]  A. Gessain,et al.  Sporadic inclusion body myositis in a patient with human T cell leukemia virus type 1-associated myelopathy. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[104]  D. Isenberg,et al.  Autoantibody profiles in the sera of European patients with myositis , 2001, Annals of the rheumatic diseases.

[105]  H P Hartung,et al.  Expression of specific matrix metalloproteinases in inflammatory myopathies. , 2001, Brain : a journal of neurology.

[106]  W. Engel,et al.  Inclusion‐Body Myositis: Newest Concepts of Pathogenesis and Relation to Aging and Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.

[107]  N. Darín,et al.  Autosomal dominant myopathy: missense mutation (Glu-706 --> Lys) in the myosin heavy chain IIa gene. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[108]  F. Breedveld,et al.  Epidemiology of inclusion body myositis in the Netherlands: A nationwide study , 2000, Neurology.

[109]  S. Tabrizi,et al.  Sporadic inclusion body myositis not linked to prion protein codon 129 methionine homozygosity , 2000, Neurology.

[110]  R. Wada,et al.  Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[111]  J. Garcia,et al.  MRI in inflammatory myopathies , 2000, Skeletal Radiology.

[112]  J. Malley,et al.  Disease progression in sporadic inclusion body myositis: Observations in 78 patients , 2000, Neurology.

[113]  F L Mastaglia,et al.  Prevalence of sporadic inclusion body myositis in Western Australia , 2000, Muscle & nerve.

[114]  K. Pile,et al.  Inclusion body myositis associated with systemic lupus erythematosus (SLE) , 2000, Australian and New Zealand journal of medicine.

[115]  R. Mantegazza,et al.  Increased Expression of β‐Chemokines in Muscle of Patients with Inflammatory Myopathies , 2000, Journal of neuropathology and experimental neurology.

[116]  M. Dalakas,et al.  Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies , 2000, Neurology.

[117]  I. Lundberg,et al.  Safety of a home exercise programme in patients with polymyositis and dermatomyositis: a pilot study. , 1999, Rheumatology.

[118]  G. Yosipovitch,et al.  STIR magnetic resonance imaging: a noninvasive method for detection and follow-up of dermatomyositis. , 1999, Archives of dermatology.

[119]  W. Declercq,et al.  Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies 1 This paper was presented at the 50th Annual Meeting of the American Academy of Neurology, Minneapolis, MN, USA, April 1998. 1 , 1999, Neuromuscular Disorders.

[120]  M. Pawlita,et al.  UDP-GlcNAc 2-epimerase: a regulator of cell surface sialylation. , 1999, Science.

[121]  C. Witt,et al.  Mapping of a candidate region for susceptibility to inclusion body myositis in the human major histocompatibility complex , 1999, Immunogenetics.

[122]  N. Darín,et al.  Dominant hereditary inclusion-body myopathy gene (IBM3) maps to chromosome region 17p13.1. , 1999, American journal of human genetics.

[123]  Hagen H. Kitzler,et al.  Methionine homozygosity at prion gene codon 129 may predispose to sporadic inclusion-body myositis , 1999, The Lancet.

[124]  F. Christiansen,et al.  The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases , 1999, Immunological reviews.

[125]  M. Ferrante,et al.  The wide spectrum of myofibrillar myopathy suggests a multifactorial etiology and pathogenesis , 1998, Neurology.

[126]  M. Dalakas,et al.  Molecular immunology and genetics of inflammatory muscle diseases. , 1998, Archives of neurology.

[127]  J R Lindsey,et al.  Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy. , 1998, The American journal of pathology.

[128]  A Seller,et al.  Normal in vivo skeletal muscle oxidative metabolism in sporadic inclusion body myositis assessed by 31P-magnetic resonance spectroscopy. , 1998, Brain : a journal of neurology.

[129]  D. Arnold,et al.  Intracellular phosphates in inclusion body myositis—A 31P magnetic resonance spectroscopy study , 1998 .

[130]  A. Amato,et al.  Inclusion body myositis in twins , 1998, Neurology.

[131]  N. Darín,et al.  Autosomal dominant myopathy with congenital joint contractures, ophthalmoplegia, and rimmed vacuoles , 1998, Annals of neurology.

[132]  E. Shoubridge,et al.  Characterization of the mitochondrial DNA abnormalities in the skeletal muscle of patients with inclusion body myositis. , 1998, Journal of neuropathology and experimental neurology.

[133]  K. Felice,et al.  Further observations on forearm flexor weakness in inclusion body myositis , 1998, Muscle & nerve.

[134]  M. Dalakas,et al.  HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies , 1998, Journal of Neuroimmunology.

[135]  R. Hennekam,et al.  Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy. , 1998, Arthritis and rheumatism.

[136]  G. Jansen,et al.  Absence of characteristic features in two patients with inclusion body myositis , 1998, Journal of neurology, neurosurgery, and psychiatry.

[137]  A. Seeber,et al.  Improvement of physical fitness and muscle strength in polymyositis/dermatomyositis patients by a training programme. , 1998, British journal of rheumatology.

[138]  M. Dalakas,et al.  Immune‐mediated conditions and antibodies associated with sporadic inclusion body myositis , 1998, Muscle & nerve.

[139]  K. Hayakawa,et al.  Magnetic resonance imaging of skeletal muscles in the polymyositis , 1997, Muscle & nerve.

[140]  M. Dalakas,et al.  Safety and efficacy of strength training in patients with sporadic inclusion body myositis , 1997, Muscle & nerve.

[141]  W. Reutter,et al.  A Bifunctional Enzyme Catalyzes the First Two Steps in N-Acetylneuraminic Acid Biosynthesis of Rat Liver , 1997, The Journal of Biological Chemistry.

[142]  U. Andersson,et al.  Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. , 1997, Arthritis and rheumatism.

[143]  M. Dalakas,et al.  Magnetic resonance imaging of the forearm as a diagnostic aid in patients with sporadic inclusion body myositis , 1997, Neurology.

[144]  M. Dalakas,et al.  An inflammatory, familial, inclusion body myositis with autoimmune features and a phenotype identical to sporadic inclusion body myositis. Studies in three families. , 1997, Brain : a journal of neurology.

[145]  J. Dambrosia,et al.  Treatment of inclusion-body myositis with IVIg , 1997, Neurology.

[146]  M. Dalakas,et al.  Inclusion body myositis and paraproteinemia: Incidence and immunopathologic correlations , 1997, Annals of neurology.

[147]  K. Weisgraber,et al.  Apolipoprotein E and apolipoprotein E messenger RNA in muscle of inclusion body myositis and myopathies , 1996, Annals of neurology.

[148]  S. Love,et al.  Apolipoprotein E allele frequencies in sporadic inclusion body myositis , 1996, Muscle & nerve.

[149]  J Miller,et al.  Inclusion body myositis in HIV-1 and HTLV-1 infected patients. , 1996, Brain : a journal of neurology.

[150]  T. Crawford,et al.  Congenital muscular dystrophy with primary laminin α2 (merosin) deficiency presenting as inflammatory myopathy , 1996 .

[151]  M. Dalakas,et al.  The spectrum of familial inclusion body myopathies in 13 families and a description of a quadriceps-sparing phenotype in non-Iranian Jews , 1996, Neurology.

[152]  G. Gronseth,et al.  Inclusion body myositis: Clinical and pathological boundaries , 1996, Annals of neurology.

[153]  J. A. Alexander,et al.  Hepatitis C and inclusion body myositis. , 1996, The American journal of gastroenterology.

[154]  A. Roses,et al.  Apolipoprotein E alleles in sporadic inclusion‐body myositis and hereditary inclusion‐body myopathy , 1996, Annals of neurology.

[155]  S. Dimauro,et al.  Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: A study of 56 patients , 1996, Annals of neurology.

[156]  A. Engel,et al.  Myofibrillar Myopathy with Abnormal Foci of Desmin Positivity. II. Immunocytochemical Analysis Reveals Accumulation of Multiple Other Proteins , 1996, Journal of neuropathology and experimental neurology.

[157]  H. Goebel,et al.  Cytokine Expression Profile in Idiopathic Inflammatory Myopathies , 1996, Journal of neuropathology and experimental neurology.

[158]  W. Engel,et al.  Use of anti‐neurofilament antibody to identify paired‐helical filaments in inclusion‐body myositis , 1996, Annals of neurology.

[159]  W. Engel,et al.  Transfer of beta-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[160]  H. Reichmann,et al.  Glucocorticoid-sensitive hereditary inclusion body myositis , 1996, Journal of Neurology.

[161]  F. Mastaglia,et al.  Inclusion body myositis: Investigation of the mumps virus hypothesis by polymerase chain reaction , 1996, Muscle & nerve.

[162]  M. Schweitzer,et al.  Cost-effectiveness of MR imaging in evaluating polymyositis. , 1995, AJR. American journal of roentgenology.

[163]  F L Mastaglia,et al.  Apolipoprotein E ϵ4 in inclusion body myositis , 1995 .

[164]  M. Memo,et al.  Identification and Characterization of a κB/Rel Binding Site in the Regulatory Region of the Amyloid Precursor Protein Gene (*) , 1995, The Journal of Biological Chemistry.

[165]  S. Dimauro,et al.  Inclusion body myositis and myopathies , 1995, Annals of neurology.

[166]  J. Nagle,et al.  Exons 16 and 17 of the amyloid precursor protein gene in familial inclusion body myopathy , 1995, Annals of neurology.

[167]  E. Holme,et al.  Mitochondrial DNA Deletions in Muscle Fibers in Inclusion Body Myositis , 1995, Journal of neuropathology and experimental neurology.

[168]  J. Mendell,et al.  Inclusion body myositis , 1995, Neurology.

[169]  M. Dalakas,et al.  Common variable immunodeficiency and inclusion body myositis: A distinct myopathy mediated by natural killer cells , 1995, Annals of neurology.

[170]  P. Plotz,et al.  The idiopathic inflammatory myopathies: spectrum of MR imaging findings. , 1995, Radiographics : a review publication of the Radiological Society of North America, Inc.

[171]  W. Engel,et al.  Abnormal accumulation of prion protein mRNA in muscle fibers of patients with sporadic inclusion-body myositis and hereditary inclusion-body myopathy. , 1994, The American journal of pathology.

[172]  F L Mastaglia,et al.  HLA associations with inclusion body myositis , 1994, Clinical and experimental immunology.

[173]  F. Mastaglia,et al.  Search for persistent enterovirus infection of muscle in inflammatory myopathies , 1994, Journal of the Neurological Sciences.

[174]  R. Barohn,et al.  Inclusion body myositis , 1994, Neurology.

[175]  A. Oldfors,et al.  Inclusion body myositis: clinical, morphological, physiological and laboratory findings in 18 cases , 1994, Acta Neurologica Scandinavica.

[176]  W. Engel,et al.  New advances in inclusion-body myositis. , 1993, Current opinion in rheumatology.

[177]  H. Imhof,et al.  Polymyositis: MRI-appearance at 1.5 T and correlation to clinical findings. , 1993, Clinical radiology.

[178]  R. Hohlfeld,et al.  Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubes. , 1993, The American journal of pathology.

[179]  J. Galama,et al.  Polymyositis and dermatomyositis: no persistence of enterovirus or encephalomyocarditis virus RNA in muscle. , 1993, Annals of the rheumatic diseases.

[180]  P H Plotz,et al.  The Treatment of Inclusion Body Myositis: A Retrospective Review and a Randomized, Prospective Trial of Immunosuppressive , 1993, Medicine.

[181]  W. Engel,et al.  beta-Amyloid precursor protein mRNA is increased in inclusion-body myositis muscle. , 1993, Neuroreport.

[182]  S. Beyenburg,et al.  Inclusion body myositis : clinical and histopathological features of 36 patients , 1993, The clinical investigator.

[183]  M. Dalakas,et al.  Treatment of inclusion‐body myositis with high‐dose intravenous immunoglobulin , 1993, Neurology.

[184]  E. Holme,et al.  Mitochondrial DNA deletions in inclusion body myositis. , 1993, Brain : a journal of neurology.

[185]  M. Joffe,et al.  Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy. , 1993, The American journal of medicine.

[186]  R. Powell,et al.  Inclusion body myositis: an underdiagnosed condition? , 1993, Annals of the rheumatic diseases.

[187]  N. Gadoth,et al.  Vacuolar myopathy sparing the quadriceps. , 1993, Brain : a journal of neurology.

[188]  Chou Sm,et al.  Inclusion body myositis: analysis of 32 cases. , 1992, The Journal of rheumatology.

[189]  Marines C. Dalakas,et al.  Absence of persistent infection with enteroviruses in muscles of patients with inflammatory myopathies , 1992, Annals of neurology.

[190]  M. Dalakas,et al.  Viruses in idiopathic inflammatory myopathies: absence of candidate viral genomes in muscle , 1992, The Lancet.

[191]  C. Wiley,et al.  Management of dysphagia in inclusion body myositis. , 1992, Archives of otolaryngology--head & neck surgery.

[192]  W. Engel,et al.  Immunocytochemical localization of ubiquitin in inclusion body myositis allows its light‐microscopic distinction from polymyositis , 1992, Neurology.

[193]  J. Mendell,et al.  Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments. , 1991, Archives of neurology.

[194]  J. Frank,et al.  Magnetic resonance imaging in the idiopathic inflammatory myopathies. , 1991, The Journal of rheumatology.

[195]  M. Dalakas,et al.  A New Approach to the Classification of Idiopathic Inflammatory Myopathy: Myositis‐Specific Autoantibodies Define Useful Homogeneous Patient Groups , 1991, Medicine.

[196]  T. Medsger,et al.  Incidence of polymyositis-dermatomyositis: a 20-year study of hospital diagnosed cases in Allegheny County, PA 1963-1982. , 1990, The Journal of rheumatology.

[197]  R. Gherardi,et al.  Inclusion body myositis in French patients. A clinicopathological evaluation , 1990, Neuropathology and applied neurobiology.

[198]  H. W. Harris,et al.  Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[199]  R. Wortmann,et al.  Clinical heterogeneity and treatment response in inclusion body myositis. , 1989, Arthritis and rheumatism.

[200]  W J Litchy,et al.  Inclusion body myositis. Observations in 40 patients. , 1989, Brain : a journal of neurology.

[201]  A. Engel,et al.  Inclusion body myositis: The mumps virus hypothesis , 1989, Annals of neurology.

[202]  I. Nonaka,et al.  Distal myopathy with rimmed vacuole formation. A follow-up study. , 1989, Brain : a journal of neurology.

[203]  Y. Pouliot,et al.  Expression of immunoreactive major histocompatibility complex products in human skeletal muscles , 1988, Annals of neurology.

[204]  H. Neville,et al.  Spectrum of inclusion body myositis. , 1987, Archives of neurology.

[205]  H. Mitsumoto,et al.  Inclusion body myositis presenting as treatment-resistant polymyositis. , 1987, Arthritis and rheumatism.

[206]  M. Danon,et al.  Inclusion Body Myositis Associated with Systemic Sarcoidosis , 1986, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[207]  H. Goebel,et al.  Hearing loss in facioscapulohumeral dystrophy , 1986, European Journal of Pediatrics.

[208]  S. M. Chou,et al.  Inclusion body myositis: a chronic persistent mumps myositis? , 1986, Human pathology.

[209]  A. Engel,et al.  Monoclonal antibody analysis of mononuclear cells in myopathies. III: Immunoelectron microscopy aspects of cell‐mediated muscle fiber injury , 1986, Annals of neurology.

[210]  R. Yood,et al.  Inclusion body myositis and systemic lupus erythematosus. , 1985, The Journal of rheumatology.

[211]  V. Dubowitz,et al.  INCREASED EXPRESSION OF HLA ABC CLASS I ANTIGENS BY MUSCLE FIBRES IN DUCHENNE MUSCULAR DYSTROPHY, INFLAMMATORY MYOPATHY, AND OTHER NEUROMUSCULAR DISORDERS , 1985, The Lancet.

[212]  A. Engel,et al.  Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells , 1984, Annals of neurology.

[213]  A. Engel,et al.  Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis , 1984, Annals of neurology.

[214]  Z. Argov,et al.  “Rimmed vacuole myopathy” sparing the quadriceps A unique disorder in iranian jews , 1984, Journal of the Neurological Sciences.

[215]  I. Nonaka,et al.  Familial distal myopathy with rimmed vacuole and lamellar (myeloid) body formation , 1981, Journal of the Neurological Sciences.

[216]  E. Yunis,et al.  Inclusion body myositis. , 1971, Laboratory investigation; a journal of technical methods and pathology.

[217]  W. N. Dawson,et al.  The epidemiology of polymyositis. , 1970, The American journal of medicine.

[218]  S M Chou,et al.  Myxovirus-Like Structures in a Case of Human Chronic Polymyositis , 1967, Science.

[219]  T. Iwaki,et al.  Increased expression of manganese superoxide dismutase is associated with that of nitrotyrosine in myopathies with rimmed vacuoles , 2014, Acta Neuropathologica.

[220]  B. De Paepe,et al.  Chemokines in idiopathic inflammatory myopathies. , 2008, Frontiers in Bioscience.

[221]  J. Lünemann,et al.  Beta-amyloid is a substrate of autophagy in sporadic inclusion body myositis. , 2007, Annals of neurology.

[222]  Baziel G M van Engelen,et al.  Inclusion body myositis. Clinical features and clinical course of the disease in 64 patients. , 2005, Journal of neurology.

[223]  T. Krieg,et al.  [PM-Scl antibody positive systemic sclerosis associated with inclusion-body myositis]. , 2005, Zeitschrift fur Rheumatologie.

[224]  P. Muchowski,et al.  Modulation of neurodegeneration by molecular chaperones , 2005, Nature Reviews Neuroscience.

[225]  Paul D Allen,et al.  Calcium dyshomeostasis in beta-amyloid and tau-bearing skeletal myotubes. , 2004, The Journal of biological chemistry.

[226]  P. Miossec,et al.  Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: Interaction with chemokines and Th1 cytokine-producing cells. , 2004, Arthritis and rheumatism.

[227]  É. Dion,et al.  [Use of muscular MRI in inflammatory myopathies]. , 2004, La Revue de medecine interne.

[228]  J. Satoh,et al.  Interferon beta-responsive inclusion body myositis in a hepatitis C virus carrier. , 2004, Neurology.

[229]  G. Borm,et al.  Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies. , 2004, Journal of neurology, neurosurgery, and psychiatry.

[230]  Kristian Borg,et al.  Sporadic inclusion body myositis: pilot study on the effects of a home exercise program on muscle function, histopathology and inflammatory reaction. , 2003, Journal of rehabilitation medicine.

[231]  E. Masliah,et al.  Amyloid beta protein toxicity mediated by the formation of amyloid-beta protein precursor complexes. , 2003, Annals of neurology.

[232]  Pritam Das,et al.  NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo. , 2003, The Journal of clinical investigation.

[233]  M. Dalakas,et al.  Expression of IFN-gamma-inducible chemokines in inclusion body myositis. , 2003, Journal of neuroimmunology.

[234]  X. Ferrer,et al.  [Inclusion body myositis associated with sacroidosis: a report of 3 cases]. , 2001, Annales de pathologie.

[235]  R. Griggs,et al.  Distal myopathies. , 2001, Current opinion in neurology.

[236]  M. Toepfer,et al.  High-dose immunoglobulin therapy in sporadic inclusion body myositis: a double-blind, placebo-controlled study , 2000, Journal of Neurology.

[237]  B. Banwell,et al.  AlphaB-crystallin immunolocalization yields new insights into inclusion body myositis. , 2000, Neurology.

[238]  P H Plotz,et al.  Inclusion body myositis long after dermatomyositis: a report of two cases. , 1999, Clinical and experimental rheumatology.

[239]  M. Dalakas,et al.  Rimmed vacuoles with beta-amyloid and ubiquitinated filamentous deposits in the muscles of patients with long-standing denervation (postpoliomyelitis muscular atrophy): similarities with inclusion body myositis. , 1998, Human pathology.

[240]  G. Martin,et al.  Transgenic mice over-expressing the C-99 fragment of betaPP with an alpha-secretase site mutation develop a myopathy similar to human inclusion body myositis. , 1998, The American journal of pathology.

[241]  A. Pestronk,et al.  Polymyositis with cytochrome oxidase negative muscle fibres. Early quadriceps weakness and poor response to immunosuppressive therapy. , 1997, Brain : a journal of neurology.

[242]  M. Memo,et al.  Interleukin-1beta and glutamate activate the NF-kappaB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. , 1996, The Journal of biological chemistry.

[243]  Nihon Hassei Seibutsu Gakkai,et al.  Genes to cells , 1996 .

[244]  C. Harrington,et al.  Apolipoprotein E type epsilon 4 allele frequency is not increased in patients with sporadic inclusion-body myositis. , 1995, Neuroscience letters.

[245]  D. Selkoe,et al.  Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau. , 1994, The American journal of pathology.

[246]  W. Engel,et al.  Strong immunoreactivity of alpha 1-antichymotrypsin co-localizes with beta-amyloid protein and ubiquitin in vacuolated muscle fibers of inclusion-body myositis. , 1993, Acta neuropathologica.

[247]  G. Serratrice,et al.  [Inclusion body myositis and neuromuscular diseases with rimmed vacuoles]. , 1992, Revue neurologique.

[248]  L. Gutmann,et al.  Inclusion body myositis and chronic immune thrombocytopenia. , 1984, Archives of neurology.

[249]  F. Freemon,et al.  A new familial disorder of combined lower motor neuron degeneration and skeletal disorganization. , 1982, Transactions of the Association of American Physicians.

[250]  Adams Rd,et al.  A myopathy with cellular inclusions. , 1965 .